ABSTRACT
Background: Internet addiction, a serious psychological disorder, has rapidly increased among students and caused substantial interpersonal impairments. On the other hand, some evidence has indicated that impulsivity is associated with addictive behaviors. Objectives: There are a few studies concerning the relationship between internet addiction and impulsivity in Iranian students. Therefore, this study aimed to evaluate the relationship between impulsivity and internet addiction in the medical students of Golestan University of Medical Sciences, Golestan, Iran, within 2020-2021. Methods: In a cross-sectional study, 260 medical students at Golestan University of Medical Sciences in 2021 completed demographic, Barratt Impulsiveness Scale, and Young questionnaires and participated in a Go/No-Go computer test. Based on Young test scores, the students were divided into three groups of normal users, at-risk users, and users requiring treatment and compared regarding impulsivity and inhibition ability. Data was analyzed using SPSS v 23. Results: The mean age of the participants was 24.16 years. The results showed a significant correlation between impulsivity and internet addiction (p = 0.001), which was established in all contextual indicators. A significant correlation was also shown between impulsivity and internet addiction (r = 0.602 and p = 0.001), both in male and female student. However, restraint index was correlated with internet addiction only in females (r = 0.187 and p = 0.033). Conclusion: Based on these findings, impulsivity increases alongside the rising of the internet addiction severity and does not influence by gender.
ABSTRACT
BACKGROUND: Migraine is a chronic neurological disorder, characterized by recurrent moderate to severe headaches. Worldwide migraine affects nearly 15%. Studies suggest that genes involved in the production of nitric oxide (NO) may act as genetic factors for migraine. NO synthase 3 (NOS3) by expressing enzyme NOS regulates endothelial derived NO. One class of medications used as first-line treatment in migraine prophylaxis is tricyclic antidepressants (TCAs). The aim of this study was to determine effects of NOS3 gene Glu298Asp polymorphism in the production of NO and response of patients to TCAs in migraine attacks. METHODS: A total of 80 migraine patients were invited to participate in the study. Patients recorded the characteristics of their migraine attacks such as frequency of attacks and intensity of headaches for the 1(st) month of the study. Then peripheral blood samples were taken from all subjects in order to determine patients' genotype distribution, mRNA expression level of NOS3 and NO content of plasma. Patients were then instructed to use 25 mg nortriptyline at night before bed for 3 months. At the end of 3(rd) month of the treatment patients again recorded the migraine characteristics for 1 month and blood sampling was performed in order to determine the level of plasma NO. RESULTS: The patients' genotype distribution for TT, GT, and GG was 9, 24, and 47 subjects, respectively. Mean NO level in patients with TT genotype was less in comparison to GT and GG genotypes before and after use of TCAs (P < 0.05). Mean intensity of headaches in patients with TT genotype was lower in comparison to GT and GG genotypes before and after use of TCAs (based on verbal numerical rating scale). Mean frequency of migraine attacks after use of TCAs was significantly decreased in all genotypes of NOS3 Glu298Asp polymorphism particularly in TT genotype (P < 0.05). CONCLUSION: Presence of T allele of the Glu298Asp polymorphism may be a factor for TT genotype patients to produce less NO and is a favorable factor for better response to TCAs in reducing migraine attacks in comparison to GT and GG genotypes.
ABSTRACT
PROJECT: Omeprazole is one of the most frequently prescribed drugs in patients with gastroesophageal reflux disease (GERD). It increases the gastric pH and this in turn may change the intestinal absorption of trace elements. This study was conducted to assess the effects of omeprazole consumption on the serum level of trace elements. PROCEDURES: The studied subjects were selected from the list of patients referred to the gastroenterology department of 5 Azar hospital in Golestan province of Iran for whom omeprazole was prescribed by a gastroenterologist. Blood samples were obtained before (phase I) and after an eight-week period (phase II) of omeprazole consumption. Serum levels of trace elements were assessed by the photometric method. RESULTS: Sixty seven patients were recruited of whom, 35.82% were males. There was no significant difference in serum levels of Fe, P, Ca and Cu between phases I and II. Serum concentration of Zn was significantly lower in phase II than I (P=0.02). The proportion of male patients with low Zn levels was significantly higher in phase II (50%) than I (16.7%) (P=0.01). We found no significant difference in the proportion of female patients with low Zn levels between phase I (37.2%) and phase II (27.9%). CONCLUSIONS: We found no significant reduction in serum levels of Fe, P, Ca and Cu in phase II. However, our results showed that serum level of Zn was significantly lower after omeprazole consumption in males. So, nutritional supplement of Zn should be considered in male patients treated with omeprazole.
